Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Candel Therapeutics to Participate in the Canaccord Genuity 43rd Annual Growth Conference
-
Faron to Participate in Fireside Chat at the Canaccord Genuity 43rd Annual Growth Conference
-
Sensei Biotherapeutics to Participate in Canaccord Genuity’s 43rd Annual Growth Conference
-
The Fresh Factory Announces Renewal of Share Buyback Program
-
Cara Therapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference
-
Bitfarms to Participate in the Canaccord Genuity 43rd Annual Growth Conference August 9 - 10
-
Clene to Present at the Canaccord Genuity 43rd Annual Growth Conference
-
Voyager Therapeutics to Present at the Canaccord Genuity Growth Conference
-
Form 8.3 - [Form-8.3 EMIS GROUP PLC 01 08 2023] - (CGWL)
-
Thorne HealthTech Schedules Second Quarter 2023 Earnings Release and Conference Call for August 8
-
MicroStrategy Announces Second Quarter 2023 Financial Results
-
Red Cat Holdings to Present at the Canaccord Genuity 43rd Annual Growth Conference
-
TAG Oil Announces Upsized $11 Million Bought-Deal Public Offering
-
Coinbase (COIN) price target doubled at Canaccord Genuity on ETFs and Ripple v. SEC decision
-
Artivion to Participate in Upcoming Investor Conferences
-
APNIMED to Participate in the 43rd Annual Canaccord Genuity Global Growth Conference
-
Olema Oncology to Present at the Canaccord Genuity 43rd Annual Growth Conference
-
ACI Worldwide to Attend Upcoming Investor Conferences
-
InMode to Present at Upcoming Investor Conferences and Events
-
Coinbase Global Inc. (COIN) PT Raised to $140 at Canaccord Genuity, Sees "follow-through momentum in Q2"
-
Form 8.3 - [Form-8.3 EMIS GROUP PLC 31 07 2023] - (CGWL)
-
Seres Therapeutics to Present at Canaccord Genuity 43rd Annual Growth Conference
-
Castle Biosciences to Present at the Canaccord Genuity 43rd Annual Growth Conference
-
Propel to Participate in Fireside Chat at Canaccord’s 2023 Growth Conference
-
Passage Bio to Participate in Upcoming Investor Conferences
-
Traeger to Participate in the Canaccord Genuity 43rd Annual Growth Conference
-
Protalix BioTherapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference
-
Nuvalent to Participate in Upcoming August Investor Conferences
-
Biodesix to Participate in the Canaccord Genuity 43rd Annual Growth Conference
-
Arrow Announces Total Voting Rights (TVR) Update
-
Coho Collective Kitchens Inc. Announces Filing of New Offering Document
-
UGE Announces Best Efforts Overnight Marketed Offering of up to US$5 Million of Project Development Green Bonds
-
TAG Oil Announces $10 Million Bought-Deal Public Offering
-
ICF to Present at the Canaccord Genuity 43rd Annual Growth Conference
-
AngioDynamics to Participate in a Fireside Chat at the Canaccord Genuity Growth Conference
-
Atara Biotherapeutics to Participate in the Canaccord Genuity 43rd Annual Growth Conference
-
TPG, Francisco to take software firm New Relic private in $6.5 billion deal
-
Turnium Technology Group, Inc. Provides Update Regarding Previously Announced Brokered LIFE Offering For Up to C$3.5 Million
-
New Relic Announces First Quarter Fiscal Year 2024 Results
-
RenovoRx to Present at the 43rd Annual Canaccord Genuity Growth Conference
-
Reviva Pharmaceuticals to Present at Upcoming Investor Conferences in August
-
DocGo Announces Upcoming Participation at Canaccord Genuity 43rd Annual Growth Conference
-
Juggernaut Capital Partners and Nature's One Founder Jay Highman have sold Nature's One to Bobbie Baby, Inc
-
Form 8.3 - [EMIS Group plc - 28 07 2023] - (CGWL)
-
Ucore Announces Closing of Final Tranche of Private Placement for Total Gross Proceeds of $4.82 Million
-
T2 Biosystems to Attend Upcoming Investor Conferences
-
Paragon 28 to Present at the Canaccord Genuity 43rd Annual Growth Conference
-
Thorne HealthTech to Participate in the Canaccord Genuity 43rd Annual Growth Conference on August 10
-
VOLT LITHIUM ANNOUNCES FILING OF PROSPECTUS SUPPLEMENT IN RESPECT OF $6 MILLION MARKETED PUBLIC OFFERING OF UNITS AND ANNOUNCES $1.2 MILLION CONCURRENT PRIVATE PLACEMENT OF UNITS
-
Vivid Seats to Participate in Canaccord Genuity’s 2023 Growth Conference

